TGF-α differentially regulates GFAP, vimentin, and nestin gene expression in U-373 MG glioblastoma cells: Correlation with cell shape and motility

Experimental Cell Research

Volumn 254, Issue 2, 2000, Pages 269-278

  Zhou, Rixin ^a   Skalli, Omar ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Astrocyte; EGF receptor; Glioma; Growth factor; Intermediate filament

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE FILAMENT PROTEIN; MESSENGER RNA; NESTIN; TRANSFORMING GROWTH FACTOR ALPHA; VIMENTIN;

ARTICLE; ASTROCYTOMA; CELL MOTILITY; CELL SHAPE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; INTERMEDIATE FILAMENT; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL LINE;

EID: 0034141568     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4762     Document Type: Article

References (51)

1. Van der Valk P., Lindeman J., Kamphorst W. Growth factor profiles of human gliomas. Do non-tumour cells contribute to tumour growth in glioma. Ann. Oncol. 8:1997;1023-1029.
2. Rutka J. T., Murakami M., Dirks P. B., Hubbard S. L., Becker L. E., Fukuyama K., Jung S., Tsugu A., Matsuzawa K. Role of glial filaments in cells and tumors of glial origin: A review. J. Neurosurg. 87:1997;420-430.
3. Sultana S., Zhou R., Sadagopan M. S., Skalli O. Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins. Am. J. Pathol. 153:1998;1157-1168.
4. Lee D. C., Fenton S. E., Berkowitz E. A., Hissong M. A. Transforming growth factor α: Expression, regulation, and biological activities. Pharmacol. Rev. 47:1995;51-85.
5. Samuels V., Barrett J. M., Bockman S., Pantazis C. G., Allen M. B. Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am. J. Pathol. 134:1989;895-902.
6. Schlegel U., Moots P. L., Rosenblum M. K., Thaler H. T., Furneaux H. M. Expression of transforming growth factor alpha in human gliomas. Oncogene. 5:1990;1839-1842.
7. Yung W. K., Zhang X., Steck P. A., Hung M. C. Differential amplification of the TGF-α gene in human gliomas. Cancer Commun. 2:1990;201-205.
8. Bigner S. H., Humphrey P. A., Wong A. J., Vogelstein B., Mark J., Friedman J., Bigner D. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res. 50:1990;8017-8022.
9. U H. S., Espiritu O. D., Kelley P. Y., Klauber M. R., Hatton J. D. The role of the epidermal growth factor receptor in human gliomas. 1. The control of cell growth. J. Neurosurg. 82:1995;841-846.
10. Louis D. N. A molecular genetic model of astrocytoma histopathology. Brain Pathol. 7:1997;755-764.
11. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, New York.
12. Srivasta R. A. K., Schonfeld G. Measurement of rate of transcription in isolated nuclei by nuclear "run-off" assay. Harwood A. J. Methods in Molecular Biology. 1994;281-289 Humana Press, Totowa.
13. Burton K. Determination of DNA concentration with diphenylamine. Methods Enzymol. 12:1968;163-166.
14. Lewin B. Gene Expression. 1980;Wiley-Liss, New York. p. 958.
15. Warthoe P., Bauer D., Rohde M., Strauss M. Detection and identification of expressed genes by differential display. Dieffenbach C. W., Dveksler G. S. PCR Primer: A Laboratory Manual. 1995;421-438 Cold Spring Harbor Laboratory Press, Plainview.
16. Berens M. E., Rief M. D., Loo M. A., Giese A. The role of extracellular matrix in human astrocytoma migration and proliferation studied in a microliter scale assay. Clin. Exp. Metastasis. 12:1994;405-415.
17. Kumanishi T., Usui H., Ichikawa T., Nishiyama A., Katagiri T., Abe S., Yoshida Y., Washiyama K., Kuwano R., Sakimura K., Takahashi Y., Minoshima S., Fukuyama R., Shimizu N. Human glial fibrillary acidic protein (GFAP): Molecular cloning of the complete cDNA sequence and chromosomal localization (chromosome 17) of the GFAP gene. Acta Neuropathol. (Berlin). 83:1992;569-578.
18. Ferrari S., Battini R., Kaczmarek L., Rittling S., Calabretta B., de Riel J. K., Philiponis V., Wei J. F., Baserga R. Coding sequence and growth regulation of the human vimentin gene. Mol. Cell. Biol. 6:1986;3614-3620.
19. Perreau J., Lilienbaum A., Vasseur M., Paulin D. Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene. 62:1988;7-16.
20. Dahlstrand J., Zimmerman L. B., McKay R. D. G., Lendahl U. Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. J. Cell Sci. 103:1992;589-597.
21. Bigner D. D., Bigner S. H., Ponten J., Westermark B., Mahaley M. S., Ruoslahti E., Herschman H., Eng L. F., Wikstrand C. J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 40:1981;201-229.
22. Valles S., Pitarch J., Renau-Piqueras J., Guerri C. Ethanol exposure affects glial fibrillary acidic protein gene expression and transcription during rat brain development. J. Neurochem. 69:1997;2484-2493.
23. Chiu F. C., Goldman J. E. Synthesis and turnover of cytoskeletal proteins in cultured astrocytes. J. Neurochem. 42:1984;166-174.
24. Morrison R. S., De Vellis J., Lee Y. L., Bradshaw R. A., Eng L. F. Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes. J. Neurosci. Res. 14:1985;167-176.
25. Lendahl U., Zimmerman L. B., McKay R. D. G. CNS stem cells express a new class of intermediate filament protein. Cell. 60:1990;585-595.
26. Toyama T., Lee V. M. Y., Rorke L. B., Marvin M., McKay R. D. G., Trojanowski J. Q. Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab. Invest. 66:1992;303-313.
27. Dahlstrand J., Collins P. V., Lendhal U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res. 52:1992;5334-5341.
28. Clarke S. R., Shetty A. K., Bradley J. L., Turner D. A. Reactive astrocytes express the embryonic intermediate neurofilament nestin. NeuroReport. 5:1994;1885-1888.
29. Frisen J., Johansson C. B., Torok C., Risling M., Lendahl U. Rapid, widespread, and long-lasting induction of nestin contributes to the generation of glial scar tissue after CNS injury. J. Cell Biol. 131:1995;453-464.
30. Dahlstrand J., Lardelli M., Lendahl U. Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Dev. Brain Res. 8:1995;109-129.
31. Eng L. F., Lee Y. L. Intermediate filaments in astrocytes. Kettenmann H., Ransom B. R. Neuroglia. 1995;650-667 Oxford Univ. Press, London.
32. Bignami A., Dahl D. Gliosis. Kettenmann H., Ransom B. R. Neuroglia. 1995;843-858 Oxford Univ. Press, London.
33. Herpers M. J. H. M., Ramaekers F. C. S., Alderweireldt J., Moesker O., Slooff J. Co-expression of glial fibrillary acidic protein and vimentin-type intermediate filaments in human astrocytomas. Acta Neuropathol. (Berlin). 70:1986;333-339.
34. Yung W. K., Luna M., Borit A. Vimentin and glial fibrillary acidic protein in human brain tumors. J. Neuro-Oncol. 3:1985;35-38.
35. Ben-Ze'ev A. Differential control of cytokeratins and vimentin synthesis by cell-cell contact and cell spreading in cultured epithelial cells. J. Cell Biol. 99:1984;1424-1433.
36. U H. S., Espiritu O. D., Kelley P. Y., Klauber M. R., Hatton J. D. The role of the epidermal growth factor receptor in human gliomas. II. The control of glial process extension and the expression of glial fibrillary acidic protein. J. Neurosurg. 82:1995;847-857.
37. El-Obeid A., Bongcam-Rudloff E., Sorby M., Ostman A., Nister M., Westermark B. Cell scattering and migration induced by autocrine transforming growth factor alpha in human glioma cells in vitro. Cancer Res. 57:1997;5598-5604.
38. Lund-Johansen M., Bjerkvig R., Humphrey P. A., Bigner S. H., Bigner D. D., Laerum O. D. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Res. 50:1990;6039-6044.
39. Westermark B., Magnusson A., Heldin C. H. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J. Neurosci. Res. 8:1982;491-507.
40. Chu Y. W., Runyan R. B., Oshima R. G., Hendrix M. J. Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc. Natl. Acad. Sci. USA. 90:1993;4261-4265.
41. Hendrix M. J. C., Seftor E. A., Seftor R. E. B., Trevor K. T. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am. J. Pathol. 150:1997;483-495.
42. Rutka J. T., Smith S. L. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary cDNA: Analysis of expression, proliferation and tumorigenicity. Cancer Res. 5:1993;3624-3631.
43. Rutka J. T., Hubbard S. L., Fukuyama K., Matsuzawa K., Dirks P. B., Becker L. E. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res. 54:1994;3267-3272.
44. Weinstein D. E., Shelanski M. L., Liem R. K. H. Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J. Cell Biol. 112:1991;1205-1213.
45. Murphy K. G., Hatton J. D., U H. S. Role of glial fibrillary acidic protein expression in the biology of human glioblastoma U-373MG cells. J. Neurosurg. 89:1998;997-1006.
46. von Bossanyi P., Sallaba J., Dietzmann K., Warich-Kirches M., Kirches E. Correlation of TGF-alpha and EGF-receptor expression with proliferative activity in human astrocytic gliomas. Pathol. Res. Pract. 194:1998;141-147.
47. Pollack I. F., Randall M. S., Kristofik M. P., Kelly R. H., Selker R. G., Vertosick F. T. Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. J. Neurosurg. 73:1990;106-112.
48. Werner M. H., Humphrey P. A., Bigner D. D., Bigner S. H. Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines. Acta Neuropathol. (Berlin). 77:1988;196-201.
49. Westphal M., Brunken M., Rohde E., Herrmann H. D. Growth factors in cultured human glioma cells: Differential effects of FGF, EGF and PDGF. Cancer Lett. 38:1988;283-296.
50. Spear M. A., Herrlinger U., Rainov N., Pechan P., Weissleder R., Breakefield X. O. Targeting gene therapy vectors to CNS malignancies. J. Neurovirol. 4:1998;133-147.
51. Vandier D., Rixe O., Brenner M., Gouyette A., Besnard F. Selective killing of glioma cell lines using an astrocyte-specific expression of the herpes simplex virus-thymidine kinase gene. Cancer Res. 58:1998;4577-4580.